Used InMode Devices for Sale: Models, Used Prices and Transfer Fee

InMode makes six device lines tracked here, from the Morpheus8 (RF microneedling) to the Evolve (hands-free body platform).

The table shows dealer asking prices read in November 2026.

Rows overlap, because one InMode workstation often carries several handpieces: a 2022 Optimas with Morpheus8, Diolaze, Lumecca and Forma was listed at $79,000 and counts in the Morpheus8 and Lumecca rows.

Price follows the console generation more than the brand name, so a 2018 Embrace RF with a Morpheus8 Face handpiece was listed at $12,995 while a 2024 IgniteRF with Morpheus8 Burst handpieces was listed at $65,899.

A 2023 Define with Morpheus8, Define and Forma handpieces was listed at $49,500, and Define has no model page here yet.

To set these numbers against other makers, use the price guide comparing InMode with other used laser makers.

Used InMode devices are listed at $6,000 to $89,950 as of November 2026, with an Evolve on a dealer listing at the top and a Votiva at the bottom.

Morpheus8 systems are the most listed InMode line, at $12,995 to $79,000 across 13 listings from 9 sellers, with a median asking price of $23,750.

These are asking prices on dealer listings, not sale prices.

InMode generally gives a 12-month warranty on its products and sells maintenance and support after that on a service-contract basis.

Every InMode product is a platform plus one or more handpieces or hands-free applicators, a one-time disposable tip or handpiece, and proprietary software.

• Service source: InMode sells maintenance and support on a service-contract basis after the warranty; ask the seller who maintained the unit.
• Handpieces: handpieces trade on their own, such as a 2022 Morpheus8 face handpiece listed at $4,500 and a 2025 Morpheus8 Burst handpiece for Optimas MAX listed at $12,500.
• Consumables: resellers list new single-use Morpheus8 tips at $60 to $195 each, and one lists a box of 4 at $670 (November 2026).

Morpheus8, Morpheus8 Body, Morpheus8 Burst and Morpheus8V handpieces run on the BodyTite, EmbraceRF, Optimas, IgniteRF, OptimasMAX, EmpowerRF, Envision and Define platforms, per InMode's 2025 annual report.

Consumables and service brought InMode $81.4 million of its $370.5 million revenue in 2025, about 22% of the total.

InMode does not publish a transfer or recertification fee for used systems (checked November 2026).

Its 2025 annual report and its US customer-service page contain no transfer, recertification, resale or pre-owned policy.

Some dealers state the terms in the listing, such as an EvolveX listed at $88,899 and sold with manufacturer recertification.

Before you pay a seller, ask InMode in writing, with the serial number, whether a new owner can buy tips and a service contract and what that costs.

To compare InMode with Candela, Cynosure and Cutera, see transfer and recertification fees for InMode's competitors.

InMode does not say publicly whether a system bought from a dealer or another clinic can get an InMode service contract.

Get that answer from InMode, tied to the serial number, before you close a private purchase.

InMode was established in 2008 as Invasix Ltd. and changed its corporate name to InMode in November 2017.

Search for "Fractora" as well as "Morpheus8" when you hunt for older units, because the first Morpheus8 clearance named the applicators "Morpheus8 (Fractora)".

InMode's EmFace device (510(k) K191855, 2019) is now sold as Evoke and is a different product from BTL's Emface.

InMode's co-founders Moshe Mizrahy and Dr. Michael Kreindel previously founded Syneron Medical, which merged with Candela in 2010; InMode is a separate company.

If you are a dealer with InMode stock, you can list your used InMode inventory here and reach clinic buyers.